NCT00492687 Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas Status UNKNOWN Phase PHASE2
NCT00486603 Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT00482677 Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE3
NCT00481455 Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM) Status COMPLETED Phase PHASE2
NCT00471653 Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy Status TERMINATED Phase N/A
NCT00458601 Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00441142 Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00437957 Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases Status TERMINATED Phase PHASE1
NCT00436436 O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy Status TERMINATED Phase PHASE2
NCT00433381 Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma Status COMPLETED Phase PHASE2
NCT00424554 Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed) Status COMPLETED Phase PHASE2
NCT00423150 Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) Status TERMINATED Phase PHASE2
NCT00416819 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma Status COMPLETED Phase NA
NCT00404495 Combination of Irinotecan and Temozolomide in Children With Brain Tumors. Status COMPLETED Phase PHASE2
NCT00402116 Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00401180 Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00400816 Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma Status COMPLETED Phase PHASE2
NCT00394628 AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme Status UNKNOWN Phase PHASE1/PHASE2